Mirion Technologies, Inc. (MIR) News
Filter MIR News Items
MIR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest MIR News From Around the Web
Below are the latest news stories about MIRION TECHNOLOGIES INC that investors may wish to consider to help them evaluate MIR as an investment opportunity.
Mirion Technologies Signs Agreement with TerraPower for Molten Chloride Reactor ExperimentATLANTA, November 16, 2023--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor. This collaboration reinforces TerraPower and Mirion’s commitment to fostering sustainable, low-carbon energy solutions that address climate change and support a n |
Mirion Announces Third Quarter 2023 Financial Results and Reiterates Full Year GuidanceATLANTA, November 01, 2023--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the third quarter ended September 30, 2023. Related materials will be available online at ir.mirion.com. On November 1, 2023, Mirion also closed the acquisition of ec2, with a purchase price of $33 million through an all cash purchase. |
Mirion Launches Philanthropic Partnership with RAD-AID InternationalATLANTA, November 01, 2023--Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world. |
Mirion to Present at the Baird Global Industrial ConferenceATLANTA, October 31, 2023--Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Baird Global Industrial Conference in Chicago, IL. The presentation will begin at 10:40 AM ET on Tuesday, November 7, 2023. |
Mirion Announces Departure of Medical Group PresidentATLANTA, October 18, 2023--Mirion ("we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Michael Rossi has informed the Company of his decision to resign as Medical Group President, effective November 1, 2023, in order to assume a CEO role at another public company. |
Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2023ATLANTA, October 17, 2023--Mirion (NYSE: MIR) announced today that it will release financial results for the third quarter of 2023 after market close on Wednesday, November 1, 2023. Following the news release, the company will host a conference call the next day, Thursday, November 2, 2023, at 12:00 pm ET to discuss the results. |
Mirion Technologies Gamma Detector to Play Crucial Role in NASA’s Psyche MissionATLANTA, October 16, 2023--Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced its contribution to the Psyche mission, which launched from the agency's Kennedy Space Center in Florida on October 13, 2023. A long-time contributor to space exploration and other big-science applications, Mirion has provided a specialized high-purity germanium (HPGe) gamma-ray detection component that will play a pivotal role in unlocking the mysteries of the a |
Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023Sun Nuclear, a Mirion Medical company (NYSE: MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. |
Sun Nuclear SunSCAN™ 3D Water Scanning System Receives CE MarkingSun Nuclear, a Mirion Medical company (NYSE: MIR), today announced achievement of the CE mark per EU Medical Device Regulation for the SunSCAN™ 3D cylindrical water scanning system. The SunSCAN 3D system supports linear accelerator (linac) commissioning, beam scanning and annual Quality Assurance (QA) in Radiation Therapy. Since its release in May 2022, the SunSCAN 3D system has found widespread clinical adoption in countries outside of those requiring the CE mark for its efficiency and hyper-ac |
Mirion to Present at the Jefferies Industrials ConferenceATLANTA, August 28, 2023--Mirion (NYSE: MIR) announced today that Chief Financial Officer, Brian Schopfer, will present at the Jefferies Industrials Conference in New York, NY. The presentation will begin at 9:00 AM ET on Wednesday, September 6, 2023. |